Year |
Citation |
Score |
2023 |
Rada M, Krzywon L, Petrillo S, Lazaris A, Metrakos P. A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases. Biomedicines. 11. PMID 36979711 DOI: 10.3390/biomedicines11030731 |
0.342 |
|
2022 |
Rada M, Hassan N, Lazaris A, Metrakos P. The molecular mechanisms underlying neutrophil infiltration in vessel co-opting colorectal cancer liver metastases. Frontiers in Oncology. 12: 1004793. PMID 36330498 DOI: 10.3389/fonc.2022.1004793 |
0.413 |
|
2022 |
Rada M, Kapelanski-Lamoureux A, Tsamchoe M, Petrillo S, Lazaris A, Metrakos P. Angiopoietin-1 Upregulates Cancer Cell Motility in Colorectal Cancer Liver Metastases through Actin-Related Protein 2/3. Cancers. 14. PMID 35626145 DOI: 10.3390/cancers14102540 |
0.466 |
|
2022 |
Rada M, Tsamchoe M, Kapelanski-Lamoureux A, Hassan N, Bloom J, Petrillo S, Kim DH, Lazaris A, Metrakos P. Cancer Cells Promote Phenotypic Alterations in Hepatocytes at the Edge of Cancer Cell Nests to Facilitate Vessel Co-Option Establishment in Colorectal Cancer Liver Metastases. Cancers. 14. PMID 35267627 DOI: 10.3390/cancers14051318 |
0.48 |
|
2021 |
Rada M, Kapelanski-Lamoureux A, Petrillo S, Tabariès S, Siegel P, Reynolds AR, Lazaris A, Metrakos P. Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases. Communications Biology. 4: 950. PMID 34376784 DOI: 10.1038/s42003-021-02481-8 |
0.433 |
|
2020 |
Rada M, Lazaris A, Kapelanski-Lamoureux A, Mayer TZ, Metrakos P. Tumor Microenvironment Conditions that Favor Vessel Co-option in Colorectal Cancer Liver Metastases: A Theoretical Model. Seminars in Cancer Biology. PMID 32920126 DOI: 10.1016/J.Semcancer.2020.09.001 |
0.454 |
|
2020 |
Nallanthighal S, Rada M, Heiserman JP, Cha J, Sage J, Zhou B, Yang W, Hu Y, Korgaonkar C, Hanos CT, Ashkavand Z, Norman K, Orsulic S, Cheon DJ. Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer. Cell Death & Disease. 11: 258. PMID 32312965 DOI: 10.1038/S41419-020-2442-Z |
0.424 |
|
2020 |
Palmieri V, Lazaris A, Mayer TZ, Petrillo SK, Alamri H, Rada M, Jarrouj G, Park WY, Gao ZH, McDonald PP, Metrakos P. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy. The Journal of Pathology. PMID 32297656 DOI: 10.1002/Path.5449 |
0.425 |
|
2020 |
Rada M, Kapelanski-Lamoureux A, Petrillo S, Tabariès S, Siegel P, Lazaris A, Metrakos P. Abstract 3935: Runt related transcription factor-1 (runx1) plays a central role in vessel co-option of colorectal cancer liver metastases Tumor Biology. DOI: 10.1158/1538-7445.Am2020-3935 |
0.422 |
|
2020 |
Mayer TZ, Kim DH, Rada M, Petrillo S, Lazaris A, Metrakos P. Abstract 3331: Role of innate immune cells in the development of vessel co-opting CRC liver metastases Immunology. 80: 3331-3331. DOI: 10.1158/1538-7445.Am2020-3331 |
0.439 |
|
2019 |
Ibrahim NS, Lazaris A, Rada M, Petrillo SK, Huck L, Hussain S, Ouladan S, Gao ZH, Gregorieff A, Essalmani R, Seidah NG, Metrakos P. Angiopoietin1 Deficiency in Hepatocytes Affects the Growth of Colorectal Cancer Liver Metastases (CRCLM). Cancers. 12. PMID 31877668 DOI: 10.3390/Cancers12010035 |
0.464 |
|
2019 |
Ekpenyong-Akiba AE, Poblocka M, Althubiti M, Rada M, Jurk D, Germano S, Kocsis-Fodor G, Shi Y, Canales JJ, Macip S. Amelioration of age-related brain function decline by Bruton's tyrosine kinase inhibition. Aging Cell. e13079. PMID 31736210 DOI: 10.1111/Acel.13079 |
0.324 |
|
2019 |
Rada M, Lazaris A, Petrillo S, Amri A, Metrakos P. Abstract 5151: Deciphering the molecular mechanisms driving infiltrative histopathological type of colorectal cancer liver metastases Cancer Research. 79: 5151-5151. DOI: 10.1158/1538-7445.Am2019-5151 |
0.493 |
|
2018 |
Rada M, Barlev N, Macip S. BTK: a two-faced effector in cancer and tumour suppression. Cell Death and Disease. 9: 1064. PMID 30337526 DOI: 10.1038/S41419-018-1122-8 |
0.464 |
|
2018 |
Rada M, Barlev N, Macip S. BTK modulates p73 activity to induce apoptosis independently of p53 Cell Death Discovery. 4: 30. PMID 30245853 DOI: 10.1038/S41420-018-0097-7 |
0.394 |
|
2018 |
Rada M, Nallanthighal S, Cha J, Ryan K, Sage J, Eldred C, Ullo M, Orsulic S, Cheon DJ. Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer. Oncogene. PMID 29769618 DOI: 10.1038/S41388-018-0297-X |
0.472 |
|
2017 |
Rada M, Althubiti M, Ekpenyong-Akiba AE, Lee KG, Lam KP, Fedorova O, Barlev NA, Macip S. BTK blocks the inhibitory effects of MDM2 on p53 activity. Oncotarget. 8: 106639-106647. PMID 29290977 DOI: 10.18632/Oncotarget.22543 |
0.372 |
|
2017 |
Rada M, Vasileva E, Lezina L, Marouco D, Antonov AV, Macip S, Melino G, Barlev NA. Human EHMT2/G9a activates p53 through methylation-independent mechanism. Oncogene. 36: 922-932. PMID 27452519 DOI: 10.1038/Onc.2016.258 |
0.374 |
|
2017 |
Rada M, Eldred C, Sage J, Orsulic S, Cheon D. Abstract TMEM-017: COLLAGEN TYPE XI ALPHA 1 (COL11A1) IS A NOVEL STROMAL MEDIATOR OF CHEMORESISTANCE Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Tmem-017 |
0.505 |
|
2017 |
Rada M, Cha J, Sage J, Orsulic S, Cheon D. Abstract 2975: Collagen type XI alpha 1 confers cisplatin chemoresistance in ovarian cancer through inhibitor of apoptosis proteins (IAPs) Cancer Research. 77: 2975-2975. DOI: 10.1158/1538-7445.Am2017-2975 |
0.491 |
|
2016 |
Althubiti M, Rada M, Samuel J, Escorsa JM, Najeeb H, Lee KG, Lam KP, Jones GD, Barlev N, Macip S. BTK modulates p53 activity to enhance apoptotic and senescent responses. Cancer Research. PMID 27630139 DOI: 10.1158/0008-5472.Can-16-0690 |
0.43 |
|
Show low-probability matches. |